Acupuncture for Stress-predominant Mixed Urinary Incontinence

Mixed Urinary Incontinence Clinical Trial

Official title:

Electroacupuncture for Stress-predominant Mixed Urinary Incontinence: a Three-armed Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04299932
• Other study ID #: 2019-241-KY
• Status: Recruiting
• Phase: N/A
• Start date: October 9, 2020
• Est. completion date: September 30, 2023

Study information

• Verified date: January 2021
• Source: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Contact: Zhishun Liu
• Phone: +861088002331
• Email: zhishunjournal[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators plan to conduct this multi-center, three-armed, randomized controlled trial to evaluate the efficacy of electroacupuncture (EA), compared with sham electroacupuncture (SA) and waiting list (WL) on participants with stress-predominant mixed urinary incontinence (MUI).

Description:

MUI tends to present with more severe symptoms and put greater burden on the health of individual and economy of society. Current European Association of Urology (EAU) guideline on incontinence recommends to initiate treatment targeted at predominant component of MUI. However, as to whether the interventions for stress urinary incontinence (SUI) can be effectively generalized to stress-predominant MUI, there is still no powerful evidence to support it. It is necessary to seek for interventions specific to stress-predominant MUI. Results of previous studies indicated that acupuncture might help to relieve the incontinence symptoms.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 232
• Est. completion date: September 30, 2023
• Est. primary completion date: March 31, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 35 Years to 75 Years

Eligibility

Inclusion Criteria:

1. Diagnosis of MUI by the coexistence of SUI and urgency urinary incontinence (UUI) symptoms in accordance with EAU guideline;

2. Female participants aged between 35 and 75;

3. Stress index > urge index in accordance with Medical, Epidemiologic, and Social aspects of Aging(MESA) questionnaire;

4. Symptoms of MUI for at least three months, and stress IEF outnumber 50% total IEF documented in 3-day voiding diary;

5. Less than 12 micturition episodes in average 24 hours documented in 3-day voiding diary;

6. Positive cough stress test;

7. Urine leakage > 1 g in 1-hour pad test;

8. Voluntary participation in the trial and signed written informed content.

Exclusion Criteria:

1. Urgency-predominant MUI, pure SUI, pure UUI, overflow urinary incontinence (UI) and neurogenic bladder;

2. Uncontrolled symptomatic urinary tack infection;

3. Tumor in urinary system and pelvic organ;

4. Pelvic organ prolapse = degree ?;

5. Residual urine volume = 100ml;

6. History of treatments targeted at UI, such as acupuncture, PFMT and medications in the previous one month;

7. History of surgery targeted at UI or in pelvic floor, including hysterectomy;

8. Uncontrolled diabetes or severe high blood pressure;

9. Nervous system diseases that may hamper the function of urinary system, such as Multiple sclerosis, Alzheimer's disease, Parkinson's disease, spinal cord injury, cauda equina nerve injury, or multiple system atrophy;

10. Severe heart, lung, brain, liver, kidney, mental illness, coagulation dysfunction or with obvious cognitive dysfunction

11. Installed cardiac pacemaker;

12. Inconvenient or unable to walk, run, go up and down stairs;

13. Allergy to metal, severely fear of acupuncture needles or unbearable to EA;

14. Pregnant at present, plan to conceive in future one year, at lactation period or within 12 months after childbirth.

Related Conditions & MeSH terms

• Enuresis
• Mixed Urinary Incontinence
• Urinary Incontinence

Intervention

Procedure:
• Electroacupuncture
BL33 is located in the third posterior sacral foramen; BL35, 0.5 cun (˜10mm) lateral to the extremity of the coccyx; and SP6 posterior to the medial border of the tibia, 3 cun superior to the prominence of the medial malleolus. BL33 will be inserted by needles of 0.30×75mm size at the angle of 45°, inward and downward, till the depth of 60-70mm. BL35 will be inserted by needles of 0.30×75mm size, slightly outward and upward, till the depth of 60-70mm. SP6 will be inserted by needles of 0.30×40mm till the depth of 25-30mm. All the needles will be lifted, thrust and twisted evenly for three times, right after insertion, to induce the sensation of deqi. Electronic acupuncture apparatus (Yingdi KWD 808 I electro pulse acupuncture therapeutic apparatus, Changzhou Yingdi Electronic Medical Device Co., Ltd) will be connected to the three pairs of needles transversally, with continuous wave of 20 Hertz (Hz), electric current of 2-6.5 milliampere (mA) for BL33 and BL35, and 1mA-3.5mA for SP6.
• Sham electroacupuncture
Sham BL33 is in the area of 1 cun (˜20mm) horizontally outside BL33; sham BL35, 1 cun (˜20mm) horizontally outside BL35; Sham SP6, in the middle of SP6 and tendons. The three pairs of acupoints will be inserted by needles of 0.30×40mm size to a depth of 2-3mm till the needles can stand still. No manipulations will be conducted, and the sensation of deqi will not be induced. Electronic acupuncture apparatus (Yingdi KWD 808 I electro pulse acupuncture therapeutic apparatus, Changzhou Yingdi Electronic Medical Device Co., Ltd) will be connected to the three pairs of needles transversally, with continuous wave of 20Hz and minimal electric current (ideally at a degree which participant can just percept). In about 30 seconds, the electric current will be turned down, leaving the indicator light and ticking sound on.

Locations

Country	Name	City	State
China	Guang'anmen Hospital, China Academy of Chinese Medical Sciences	Beijing	Beijing
China	The third affiliated hospital of Beijing university of Chinese Medicine	Beijing	Beijing
China	Hengyang Hospital Affiliated to Hunan University of Chinese Medicine	Hengyang	Hunan
China	Jiangxi Provincial Hospital of traditional Chinese Medicine	Nanchang	Jiangxi
China	Yantai Hospital of Traditional Chinese Medicine	Yantai	Shandong

Sponsors (2)

Lead Sponsor	Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences	Ministry of Science and Technology of the People´s Republic of China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Participants' expectations of improvement to urinary incontinence	Participants in the three groups will be asked: How do you expect your urinary incontinence to be in two months? Participants will choose the answer form the following options: Much better; Better; Don't know; Same; Worse;	Baseline assessment(week 0)
Other	Participants' belief that acupuncture might help	In EA and SA groups, participants will be asked the question: Do you think your incontinence problem may be helped by acupuncture? Participants will choose the answer from the following options: Very ineffective; Fairly ineffective; Can't decide; Effective; Very effective;	Baseline assessment(week 0) and week 4.
Other	Safety assessment	Adverse events and severe adverse events will be recorded in case report form, whether related to interventions or not.	Throughout the trial
Other	Blinding assessment	Participants in both EA and SA groups will be asked the question: do you think you have received EA? Participants will choose the answer between the options of Yes or No.	Within 5 minutes after either treatment at week 8
Primary	Proportion of participants with at least 50% reduction of mean 24-hour stress incontinence episode frequency (IEF) from baseline.	The stress IEF will be documented in 3-day voiding diary.	week 8
Secondary	Proportion of participants with at least 50% reduction of urinary leakage amount from baseline.	The urinary leakage amount will be measured by 1 hour pad test.	week 8
Secondary	Change of urinary leakage amount from baseline	The urinary leakage amount will be measured by 1 hour pad test.	week 8
Secondary	Proportion of participants with at least 50% reduction of mean 24-hour stress IEF from baseline.	The stress IEF will be documented in 3-day voiding diary.	week 4,week 20 and week 32
Secondary	Change of mean 24-hour IEF from baseline.	The IEF will be documented in 3-day voiding diary.	week 4,week 8, week 20 and week 32.
Secondary	Change of mean 24-hour stress IEF from baseline	The stress IEF is documented in 3-day voiding diary.	week 4,week 8, week 20 and week 32.
Secondary	Proportion of participants with at least 50% reduction of mean 24-hour IEF from baseline	The IEF will be documented in 3-day voiding diary.	week 4,week 8, week 20 and week 32
Secondary	Change of total and sub-score of International Consultation on Incontinence Questionnaire-short form (ICIQ-SF) from baseline.	ICIQ-SF questionnaire is a validated questionnaire to assess the severity of incontinence symptoms and influence on QoL in the past four weeks. The questionnaire includes items of IEF, urinary leakage amount and general influence on life to be scored. Total number of the score ranges from 1 to 21, with higher scores representing greater severity and 2.52 as minimal clinically important differences.	week 4,week 8, week 20 and week 32
Secondary	Change of total and sub-score of Overactive Bladder Questionnaire short form (OAB-q SF) from baseline	OAB-q SF is a validated questionnaire used to assess the OAB symptom bother and the health-related quality of life (HRQL) in the past 4 weeks. The domains include coping, concern, sleep and emotional interactions. The scores are transformed to a 0- to 100-point scale, with higher scores indicating severe symptoms and better HRQL.	week 4,week 8, week 20 and week 32
Secondary	Change of mean 24-hour pad consumption from baseline	The pad consumption will be documented in 3-day voiding diary.	week 4,week 8, week 20 and week 32
Secondary	Proportion of participants with adequate improvement assessed by Patient global impression improvement (PGI-I).	PGI-I is a global index, with only one item, used to rate the participants' subject perception on symptom improvement. Participants will describe their impression from very much better to very much worse. Adequate Improvement is defined as the response of"much better" or "very much better".	week8, week 20
Secondary	Change of mean 24-hour urgency episodes from baseline	The urgency episodes will be documented in 3-day voiding diary.	week 4,week 8, week 20 and week 32
Secondary	Change of mean 24-hour micturition episodes from baseline	The micturition episodes will be documented in 3-day voiding diary.	week 4,week 8, week 20 and week 32